Company intelligence / Profile preview

Heptares Therapeutics

Welwyn Garden City, Hertfordshire, United Kingdomprnewswire.com ↗
Ownership
Public · 4565
Employees
~150
Development stage
Phase 1
01

Overview

Heptares has built a pipeline of novel medicines targeting historically undruggable or challenging GPCRs using its proprietary StaR® technology. The company has advanced candidates into clinical development for CNS disorders and immuno-oncology. It has established major partnerships with leading pharmaceutical companies to further develop and commercialize its discoveries.

Therapeutic areas
PsychiatryMetabolic DisordersOncologyRare DiseasesNeurology
Modalities
Small moleculesbiologics (including antibody therapeutics derived from StaR antigens)
Industry
Biotech
02

Drug pipeline

1 asset

HTL0014242

Phase 1
Indications
Neurological disorders, Anxiety
03

Partnerships

Pfizer Inc.AstraZeneca/MedImmune/Cubist Pharmaceuticals/MorphoSys/Takeda Pharmaceuticals

Beyond the preview

Go deeper on Heptares Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heptares Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call